Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. Oppilotech uses the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets.